tients arid others who have received multi ple transfusions may develop precipitating isoanti bodies against Australia antigen. These precipitating isoaiitibodies read wills a protein in the blood of some normal and some sick individuals, This isoantigen f Aus tralia antigen) could not be identified m being any of the known serum proteins, Australia antigen (Au(l)) has the iramunoelectrophoretie mobility of an alpha globulin and a specific gravity of less than 1.21 (6), It stains faintly with the lipidspecific dye Sudan black, indicating the presence of some lipid, It can be distin guished from the serum alpha-and beta-lipoproteins by its staining characteristics, flotation properties, and immunological specificities. Specific antibodies against Aus tralia antigen have been produced in rab bits by immunization with whole serum that contains Australia antigen followed by absorption with the sera of individuals without the protein (7).
Recent studies of blood collected in Cebu> Peru, and Rongeiap Atoll show sig nificant family clustering ot the trait (8).
In addition, the segregation data are con sistent with the hypothesis that individuals homozygous for an allele A a 1 (genotype An 1 jAn 1 ) have detectable Australia antigen (phenotype Au(J)) while those homozygous for an alternative allele (AujAu) and beterozygotes (A u L jA u) have no detectable an tigen (phenotype Au(0))» Pending the ac quisition of additional data, this genetic hypothesis has been proposed to explain the family clustering in the populations tested.
With the use of human and rabbit antisera. the distribution of Ati(I) in several normal and patient populations has been determined (2, 8) . Au(l) is absent in normal U. S, populations and rare in north Euro pean populations (approximately 1 /1,000) but is fairly common in some Southeast Asian and Mediterranean populations. It is also relatively common in patient* with leu kemia, particularly in those with acute granulocytic leukemia (see below).
The original finding of Au{l) in very low frequency in normal individuals and in (tents with Down's syndrome (9, 10). in the present paper, we describe our further studies on the prevalence of Au(I) in Down's s y u (I mm e patients.
MATERIAL AND METHODS
Blood specimens were obtained from 75 male residents o£ the State Colony at New Lisbon, N. J. f who were admitted with die diagnosis of mongolism. For a control group, blood speci mens were obtained from 76 male residents with the diagnosis of "epilepsy," The age dis tribution was approximately the same as in die Down's syndrome group, and they had been institutionalized for approximately die same length of time. The admitting diagnoses of residents at New Lisbon Stale Colony are sup plied by die patient's local physician, and these in general are not altered alter admission. Chro mosome studies were performed on 17 of the Down's syndrome patients arid -J of the con trols (sec below).
After die identification o! Down's syndrome patients with and without detectable Australia antigen, a second collection was undertaken in which blood was withdrawn from \9 residents with Au(l) and 26 residents without it. A series of it sis were performed on these samples. The white blood cell, red blood eell, and platelet counts, the white blood eeH differential count, hemoglobin concentration, and hematocrit vol ume were determined using standard laboratory methods. We are indebted to D»\ R, A. Hlood specimens from nine. Down's syndrome residents (five girls and tour boys) of a Mary land instimtion for mentally retarded children were also tested. Blood from patients with poly cythemia vera was obtained a* three different dimes. These included 14 patients from Phila delphia, 36 from Portland, Ore., and 3? from Sun Frandsco. Other sera from patients were collected primarily in die Philadelphia aim, JS noted In the Acknowledgments section. Venous blood was collected into dry Vaeutainers (Kecton, Dickinson Co.) or test, tubes. The blond was allowed to dot overnight and the serum, removed by centrifugation. In some cases, small amounts of sera were separated from ihe hlood immediately after collection and used in the double diffusion tests, Sera were stored at -20 C for later testing. Double diffusion in agar gels was done by a micro-OuchLeijony technique described pre viously (15). Double diffusion in agar gd tubes was done by the method of Freer and Freer (10). Chromosome studies were pei formed on leukocyte cultures from M of ihe Down's syn drome patients using a method recently de scribed (17) .
Ihe clu-square determinations were done as described by Sneclcor (18). When any of the twoby-two table cells contained numbers lower than five, Fisher's exart method was used-Stu dent's i test was used for comparing the quan titative results obtained on the antigen-positive and -negative bloods. Where appropriate, the method for comparing unpaired series of num bers was used. ~ * ""™ ~~ "" •* --lateragl Medicine 
PATIENTS
Nearly 30% of the Down s syndrome pa tients had detectable Australia antigen la their serum. This includes (Table I) 19 of the 75 males from the New Jersey institu tion and 3 of 5 females and 3 of 4 mates from the Maryland institution. This repre sents the highest frequency found in any patient group so far tested. Four of the 16 control patients had Australia antigen. Of these, three had some stigma of Down's syn drome, that is, prominent epicanthal folds, Brushfield's spots, large interpupillary dis tance, short middle phalanx of the fifth finger, "mongoloid crease" of the palm, high palatal arch, etc. However, none of these had the typical Down's syndrome chromosome pattern on examination of the peripheral blood. As noted below, mosai cism cannot be ruled out by chromosome analysis of a relatively small number of cells from a single source. The difference in frequency of Australia antigen between the Down's syndrome and the control group is highly significant (x 2 = 11.8, P < 0.001). The protein was not found in any of the normal individuals from the United States. Australia antigen has been found in pa tients with leukemia, hemophilia, and thal assemia as well as in those with Down's syndrome. Forty-eight sera from patients suspected of having either serum or infec tious hepatitis were tested. Of these, five were found to have Australia antigen. The findings in hepatitis will be described in greater detail in a subsequent paper. In addition, a single patient with Fanconi's anemia (hypoplasia of the marrow) and one patient (from Finland) with Hodgkin's dis ease have the antigen (Table I) ,
The distribution of Australia antigen in leukemia and related disease groups is given in Table 2 , The frequency is rela tively high in acute granulocytic leukemia patients and to this date has not been found in any patient with chronic granulocytic leukemia-Australia antigen was found in a single case ol the relatively rare chronic reticuloendotheliosis, None of the polycy themia vera patients had detectable Aus tralia antigen.
We have recently concluded a study on Cebu Island, the Philippines, which in cluded blood specimens from 584 patients with J eproma to us leprosy, 377 patients with tuberculoid leprosy, and 764 controls with out leprosy (19, 20) . There was a signifi cant]) higher incidence of Au(l) in the leproraatous leprosy cases as compared with either the tuberculoid leprosy cases or the controls (9.4% lepromatous, 3.4% tubercu loid, 4.8% control). This difference is even more striking ii" only young men (under 20 years) are considered (26.7% lepromatous, 7.9% tuberculoid, 5,5% controls). As noted above, Au(l) is relatively common (about 5%) in nonhospita I i/ed, apparently normal populations in several Asian and Oceanic commies including the Philippines (8). f Chronic reticuloendothciiosis, 1, acute stem cell leukemia, 1.
TABIE 2. Distribution of Australia Antigen id

AGE
The age distribution by 20-year groups of the trait in the Down's syndrome pa tients is shown in Table 3 , in which this distribution is compared with that in sev eral populations of apparently normal peo ple in whom Au(i) occurs and with that in the sera of leprosy patients and controls from Cebu. The normal and patient groups used in the comparison were selected be cause of the high frequency of Au(l) and the availability of relatively large numbers of samples. The frequency of Au(l) de creases with age in all of these populations. When each of the populations is divided hi to younger (0 to 39) and older (40+) age groups, the differences in frequency of Au(l) are statistically significant for the Cebu population (0.02 > P> 0.01) and nearly so for the Marshall Islands (0.1 > F > 0.05) but not for the others.
CHROMOSOME STUDIES
Seventeen patients of the 75 Dawn's syn drome patients included in this study were selected for cytogenetic examination. Cri teria used in the selection were low ma ternal age at birth or other indication of possible familial transmission of Hie syn drome, relatively high intelligence, and, in one case (385 H), the relatively advanced age of the patient (60 years), One case was chosen at random. The selection was made without prior knowledge of the antigen phenotype. A minimum number of 10 raetaphase chromosome counts and I karyotype analysis was made on each individual (leu kocyte cultures); in those eases in which the modal chromosome number was not 47, additional counts and analyses were made. Fourteen of the 17 patients were found to be trisomic for chromosome 21, the classi cal finding in Down's syndrome (21) . Ol die remaining 3, 1 (389H) was a mosaic of normal and trisomy-2! cells, the second (584 H) was the carrier of a 13-15/21 translocaiion and effectively trisoraic for 21, and the third (385) had only chromosomes that were entirely norma I in number and mor phology in the single cell type studied. More extensive cytogenetic analysis might have revealed additional mosaicism in which cells of subordinate clones were pres ent in low frequency, but because it is pos sible to study die chromosomes of relative!) few ceil t\pes Irom a limited number of vines, it h impossible to rule out mosaicism completely in any human. None of these three had detectable Au(I).
Oi" ihe M typical Down's syndrome pa tients (that is, with 47 chromosomes), 8 had Australia antigen. Chromosome studies were done on 4 of the control patients. None of these had the typical Down's syn drome trisomy pattern.
The blood factors studies are shown in Table 4 . With the exception ol the vitamin B ls values, there was no significant dif ference between the patients with and those without Australia antigen. The mean of the B 12 values for the positive group (Australia antigen present) was 698,6 and for the negative group (Australia anti gen absent). 341.3. This gives a i value of 2.926 and 0,01 > P> 0.001 and indi cates that it is highly unlikely that this difference between the means is due to chance. The levels of white blood cell galaotose-l-phosphate uridyl transferase and glutcose-6-phosphate dehydrogenase are higher on the average in the Au(l) than the Au(0) patients, but this difference is not signifi cant. They are considerably higher than the values given for normal white hlood cells in the table published by Mellman and colleagues (13). The hematocrit reading, mean corpuscular volume, mean corpuscu lar hemoglobin, and mean corpuscular hemoglobin concentration for all the Down's syndrome patients combined are slightly higher than those for normals, con firming the findings of Naiman, Oski, and Mellman (22) . The average of the uric acid levels for all patients combined is about, the same as that found for male Down's syndrome patients by Mem, Fuller, and Concon (25) (who used a different tech nique for measuring uric acid). They noted that young mongoloids had higher levels than did the control patients.
DISCUSSION
There is a significantly higher frequency of Au(I) in the Down's syndrome patients 929 than in the controls. From this, we may conclude that the high frequency is asso ciated with Down's syndrome and that it is not due to institutionalization alone. The frequency appears to decrease with age in the Down's syndrome patients as it does in other populations. There is a higher aver age vitamin B 12 Level in the Au(l) individu als compared with the Au(0), but this finding should be confirmed before further comment is warranted. All the Down's syn drome patients with Au(l) and whose chro mosome complement is known have the usual 21 trisomy.
The present state of knowledge concern ing Australia antigen has been summarized in the introduction. The most striking fea ture of our data is the discovery of Aus tralia antigen in high frequency in patients with Down's syndrome, leukemia (par ticularly acute granulocytic leukemia and chronic lymphocytic leukemia), and viral hepatitis. These diseases have been linked lor other reasons: Patients with Down's syndrome have an increased risk of develop ing leukemia, particularly acate myeloge nous leukemia (J 1); an association has been found between epidemics of hepatitis and the birth 0 months later of children with Down's syndrome (24) ; furthermore, it has been rcponed thai sera of patients conva lescing from hepatitis cause chromosome aberrations in tissue cultures (25) .
Most of die disease associations could be explained by the association of Au(I) with a virus, as suggested in our previous publi cations (2, 6, 8) . The discovery of the fre quent occurrence of Au(J) in patients with virus hepatitis raises the possibility that the agent present in some cases of this disease may be Australia antigen or be responsible for its presence, The presence of Australia antigen in the thalassemia and hemophilia patients could be due to virus introduced by transfusions. This, however, could not be the only explanation, since many trans fused patients neither have the antigen nor an antibody against it. To our knowledge, none ol ihe Down's patients with Australia antigen have received transfusions, and its presence in these patienis may be die result of very early or maternal infection. Associa tions between Down's syndrome and thy roiditis (26) and rubella {27} have also been suggested, but these have not been studied in respect to Au(l).
As noted in the introduction, a striking family clustering of Au(l) has been found in Filipino and other populations (S). This could be explained 011 a simple infection hypothesis it the attack rate were higher in children than it is in adults. (See Table 3 of tills paper and Table 5 of reference 8.) However, the segregation in the families is consistent with simple autosomal recessive inheritance. II Au(!) is inherited, as these results suggest, this would require an ex planation consistent with the infection theory. It is possible that the trait is in herited in some groups such as the Filipinos but not in others. Or, the presence of the appropriate genes may confer an added sus ceptibility to infection with the virus. In areas where infection is very common, the trait could follow a pattern of mendelian segregation as it appeared to do in the Philippine studies.
Studies on the biochemical and immuno logic nature of Au(l) are in progress, as are additional studies on the association with hepatitis. When the results of these are available, a more explicit interpretation may be possible.
SUMMARY
Australia antigen (Au{l)) found in pa tients with leukemia (particularly those with acute granulocytic leukemia) has now been found in high frequency in patients with Down's syndrome and virus hepatitis. Down's syndrome patients with Australia antigen have, on the average, a higher level of vitamin B 12 than do the patients without this trait. Several hypotheses are discussed in an attempt to explain the associations.
